Latest News

Date Title Topic
05 May 2014 Withdrawal of Application for EMA Change to the Marketing Authorisation of Pazopanib Gynaecologic malignancies - Anticancer agents & Biologic therapy
02 May 2014 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Two HPV Vaccines Cancer prevention - Gynaecologic malignancies - Gastrointestinal cancers
07 Jul 2014 Updated 2014 ESMO Clinical Practice Guidelines
30 Apr 2014 ESMO E-Learning: Future Directions in Clinical Research of NSCLC
30 Apr 2014 The Role of Postoperative Radiation Therapy for Endometrial Cancer Gynaecologic malignancies
29 Apr 2014 EMA Recommends Granting a Marketing Authorisation for Trametinib and Extending Indications for Sorafenib Melanoma - Endocrine cancers - Anticancer agents & Biologic therapy
28 Apr 2014 ESMO V-Learning: Inhibition of MEK to Treat Cancer, focussing on Melanoma
28 Apr 2014 EORTC and SIOG Update Expert Opinion on Management of Elderly Patients with NSCLC Cancer in Special Situations - Lung and other thoracic tumours
Curriculum in Translational Research in Breast Cancer
25 Apr 2014 Recommendations for a Molecular Diagnostics Curriculum Personalised medicine - Bioethics, legal and economic issues - Translational research
25 Apr 2014 ESMO is Hiring
24 Apr 2014 Biomarker Enrichment Strategies Personalised medicine - Translational research
23 Apr 2014 FDA Approves Ramucirumab for Gastric Cancer or Gastroesophageal Junction Adenocarcinoma Gastrointestinal cancers
22 Apr 2014 New Options for Treatment of Metastatic Sarcoma Pose a Challenge in Selecting the Best One Sarcomas